Methods and kits to treat chronic inflammatory immune diseases by administering a proteasome inhibitor and an interleukin 2 receptor agonist
First Claim
Patent Images
1. A method of treating a mammal suffering from an immune condition, comprising administering to the mammal a course of treatment comprising a combination of an interleukin 2 receptor agonist and a proteasome inhibitor.
0 Assignments
0 Petitions
Accused Products
Abstract
Methods and kits for treatment of immune diseases with an IL2 receptor agonist and a proteasome inhibitor are provided.
-
Citations
26 Claims
- 1. A method of treating a mammal suffering from an immune condition, comprising administering to the mammal a course of treatment comprising a combination of an interleukin 2 receptor agonist and a proteasome inhibitor.
- 21. A use of a combination of a proteasome inhibitor and an interleukin 2 receptor agonist to induce apoptosis selectively in pathogenic CD4+ Th1 T cells.
- 24. A kit for treating an immune condition comprising a unit dose of each of an interleukin 2 receptor agonist, a proteasome inhibitor, and a container.
Specification